Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction

INTRODUCTION: Tuberculosis (TB) treatment requires the combination of multiple anti-TB drugs during 6 months or more depending on strain drug susceptibility profile. Optimizing the monitoring of anti-TB therapy efficacy is required to provide adequate care and prevent drug resistance emergence. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahuaud, Olivier, Genestet, Charlotte, Hoffmann, Jonathan, Dumitrescu, Oana, Ader, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515406/
https://www.ncbi.nlm.nih.gov/pubmed/36186786
http://dx.doi.org/10.3389/fmed.2022.998972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515406/
https://www.ncbi.nlm.nih.gov/pubmed/36186786
http://dx.doi.org/10.3389/fmed.2022.998972

Ejemplares similares